News & Research

$625,000 prize recognizes breakthrough research into cancer immunotherapy

PopEVE can identify genetic variants most likely to cause severe disease, death

Qinheng Zheng uses a daring approach to reveal new treatments for cancer

10 projects receive basic and translational research funding

“Dr. CaBot” goes head-to-head with a human expert to work through a challenging medical case

Tool identifies gene edits that boost CAR T-cell therapy effectiveness in mice

New technologies take aim at urgent challenges from autoimmune disease to cancer

Researchers hope new technologies, approaches usher in effective treatment

Molecule could hold a key to repairing tissue harmed by infection, inflammation

New model could optimize drug discovery

Underscores Harvard Medical School’s commitment to research and discovery

Could help scientists develop next-generation cancer immunotherapies, vaccines